Latest Commercialisation News

Lake Resources has increased its Measured and Indicated lithium resource at the Kachi Project in Argentina to 8.2 million tonnes LCE, revealing higher-grade lithium zones and enhanced recovery technology. This update strengthens the project's economic outlook amid ongoing feasibility and environmental assessments.

Talga Group has locked in a binding multi-year offtake agreement with Nyobolt for its Talnode-C graphite anode, marking a key commercial milestone for its Vittangi Anode Project in Sweden.

Brazilian Critical Minerals has initiated an in-situ recovery field trial at its Ema Rare Earths Project, aiming to validate the deposit's unique characteristics and advance towards commercial production.

Green Critical Minerals confirms the materiality of a formal sample request from a leading European thermal management provider, underscoring growing market interest in its VHD Graphite technology.

Neuren Pharmaceuticals has received official FDA minutes confirming the primary endpoints for its pivotal Phase 3 trial of NNZ-2591 targeting Phelan-McDermid syndrome, reinforcing the positive signals from earlier studies.

Optiscan Imaging and the Mayo Clinic have marked a year of significant progress in developing a cutting-edge imaging system designed to enhance robotic-assisted breast cancer surgery.

Solstice Minerals has completed a major Reverse Circulation drilling campaign at its Yarri Project in Western Australia, targeting promising gold prospects with assay results expected soon.

MTM Critical Metals has locked in a pre-permitted industrial site in Texas, positioning itself to commission its innovative metal recovery plant by year-end 2025 and accelerate U.S. commercial expansion.

Firebird Metals has demonstrated a breakthrough in energy efficiency with its rotary kiln technology, cutting energy consumption by more than half during manganese ore processing trials for Kazakhstan’s Taza Metal Technologies.

Zeotech Limited has successfully completed a two-year methane control program, developing a zeolite-based biofilter that reduces landfill methane emissions by more than 90%. The company is now preparing for on-site trials and commercial deployment.

Orthocell has secured regulatory approval to sell its nerve repair product Remplir™ in Hong Kong well ahead of schedule, expanding its footprint across key global markets. This milestone complements recent clearances in the US, Canada, and Asia, positioning the company for significant growth in a multi-billion-dollar market.

Nanoveu Limited has upsized its placement to $3.02 million, securing additional funding to fast-track the development and commercial rollout of its semiconductor, 3D visualisation, and solar coating technologies.